This is a prospective study on the safety and effectiveness of radiofrequency ablation in patients with desmoid tumors.
In the study group, all patients after radiofrequency ablation of the tumor after 1 month will be evaluated using MRI and CT studies and, if solid components of the tumor are detected, repeated surgical treatment is performed followed by active monitoring after 1 month.
In the absence of a solid component, the effect is estimated by the volume of the necrotic process and monitored in dynamics every 3 months.
Patients with histologically verified diagnosis of dermoid tumor
The presence of progressive, symptomatic or functionally significant DF.
Written Informed consent to participate in the study
Age from 18 to 75 years
The inability to obtain informed consent to participate in the study
Synchronous or metachronous cancer
Clinically significant diseases of the cardiovascular system
Clinically significant CNS diseases
Map coordinates are unavailable for these locations. Locations are shown below instead.
Russia